GOLDMAN SACHS GROUP INC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,891,011
+64.4%
395,609
+46.2%
0.00%
Q2 2023$1,150,224
-31.0%
270,641
-13.7%
0.00%
Q1 2023$1,666,114
-24.8%
313,769
-11.1%
0.00%
Q4 2022$2,216,193
-63.0%
352,897
-37.9%
0.00%
-100.0%
Q3 2022$5,996,000
+687.9%
568,329
+305.0%
0.00%
Q2 2022$761,000
-70.3%
140,318
-49.8%
0.00%
-100.0%
Q1 2022$2,566,000
+436.8%
279,458
+780.9%
0.00%
Q4 2021$478,00031,7230.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,266,04015.18%
Elmwood Wealth Management, Inc. 2,364,415$11,301,9045.45%
PFM Health Sciences, LP 6,724,715$32,144,1381.51%
SILVERARC CAPITAL MANAGEMENT, LLC 892,786$4,267,5171.29%
Avidity Partners Management LP 6,050,212$28,920,0131.16%
Paradigm Biocapital Advisors LP 2,944,513$14,074,7720.96%
Kynam Capital Management, LP 1,068,527$5,107,5590.84%
Green Alpha Advisors, LLC 110,524$528,3050.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,500,000$16,730,0000.37%
Bruce & Co., Inc. 200,000$956,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders